NEW YORK, June 5 – DeCode Genetics said Tuesday it has appointed Michael Young to the newly created position of vice president of business development.

In the new role, Young will be in charge of building the company’s corporate alliances for its research and product development programs.

Young, 49, previously worked at Genzyme Transgenics, where he was most recently vice president of commercial development. He has also worked as the head of business development at PerSeptive BioSystems and at Millipore.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A fire at a Manchester hospital may have destroyed lab equipment and data, the Guardian reports.

Researchers generate a genetic database from skeletal remains from the 1845 Franklin Expedition to the Arctic, Live Science reports.

Researchers in China have begun another trial using CRISPR/Cas9 approaches in cancer patients, according to the Wall Street Journal.

In Science this week: human DNA found in sediments from archeological sites lacking bones, and more.